IBRX News

Pomerantz LLP Notifies Shareholders of Class Action Filing Against ImmunityBio, Inc. – IBRX

ImmunityBio (IBRX) Facing Lawsuit After FDA Flags Misleading Cancer Claims, Shares Plunge 21%, $2B Market Cap Lost -- HBSS

IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

IBRX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026 Ready to Announce with Confidence?

IBRX DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds ImmunityBio, Inc. Investors to Join the Class Action Lawsuit Today

Pomerantz LLP Notifies Investors of Class Action Filing Against ImmunityBio, Inc. – IBRX

ImmunityBio 48 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against ImmunityBio, Inc. - IBRX

IBRX DEADLINE ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages ImmunityBio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 26 Deadline in Securities Class Action First Filed by the Firm - IBRX

Pomerantz LLP Notifies Shareholders of Class Action Against ImmunityBio, Inc. – IBRX

Bronstein, Gewirtz & Grossman LLC Urges ImmunityBio, Inc. Investors to Act: Class Action Filed Alleging Investor Harm